Error: Could not add to watchlist. X

Credit Suisse Lux Biotechnology Equity Fund

+ Watchlist
CLBIEHE:LX
334.93
EUR
0.54
0.16%
As of 00:59:30 ET on 07/02/2015.
Volume
0
Previous Close
335.47
52Wk Range
219.35 - 348.81
1 Yr Return
40.01%
Fund Type
-
Objective
-
Asset Class Focus
-
Geographic Focus
-
NAV (on 07/02/2015)
334.93
Total Assets (m EUR) (on 07/02/2015)
260.786
Inception Date
02/27/2006
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
IRENE BEATRICE PUETTNER
Front Load Fee
-
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
2.00%
Expense Ratio
-
Top Fund Holdings
Name Position Value % of Fund
Biogen Inc 47.00 k 17.57 m 7.26
Gilead Sciences Inc 167.48 k 16.83 m 6.95
Amgen Inc 105.97 k 16.73 m 6.91
Celgene Corp 140.28 k 15.16 m 6.26
Incyte Corp 130.00 k 12.63 m 5.22
BioMarin Pharmaceutical Inc 109.44 k 12.26 m 5.07
Regeneron Pharmaceuticals Inc 25.00 k 11.44 m 4.72
Vertex Pharmaceuticals Inc 85.00 k 10.48 m 4.33
Medivation Inc 80.00 k 9.66 m 3.99
Alexion Pharmaceuticals Inc 52.75 k 8.93 m 3.69
Profile
Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.
ADDRESS
Credit Suisse AG
PHONE
-